Evaluating stress urinary incontinence in postmenopausal women with osteoporosis
Official title: Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis: The Intersection of Muscle Loss and Pelvic Dysfunction
Run by Beylikduzu State Hospital · NCT06655701 · Data updated 2026-11-12
This study looks at how common stress urinary incontinence is in postmenopausal women with and without osteoporosis, and how it affects their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years to 75 Years |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | Beylikduzu State Hospital Academic / other |
| Locations | 1 site (Istanbul) |
| Status | Recruiting |
| Started | November 15, 2024 |
| Main results expected | January 15, 2025 |
| Study ends | January 15, 2025 |
| Registry record updated | December 12, 2024 |
| Trial ID | NCT06655701 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are postmenopausal women aged 50-75 with recent DXA measurements indicating either osteoporosis or non-osteoporotic status.
✕Probably not a fit
Patients with neurological diseases, psychiatric disorders, or those on medications affecting study outcomes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the prevalence of stress urinary incontinence among postmenopausal women, both with and without osteoporosis, and to evaluate its impact on their quality of life. The study will involve 100 women aged 50-75 who have undergone recent Dual-X-ray Absorptiometry (DXA) measurements. Participants will provide sociodemographic data and complete questionnaires to determine the presence of urinary incontinence and its effects on their quality of life. Additionally, the study will evaluate sarcopenia using established criteria, including assessments of muscle mass and strength.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the relationship between osteoporosis, sarcopenia, and urinary incontinence, leading to improved management strategies for affected patients.
How similar studies have gone: While the specific combination of osteoporosis, sarcopenia, and urinary incontinence has not been extensively studied, related research has shown significant associations between these conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Postmenopausal women with DXA measurements performed within the last 6 months. * Based on DXA measurements: Femoral neck and L1-L4 T-scores of -1 and above will be included in the control group (non-osteoporotic). Femoral neck and L1-L4 T-scores of -2.5 and below will be included in the osteoporosis group. * Aged 50-75 years Exclusion Criteria: * Refusal to participate in the study. * History of neurological diseases, infections, surgeries, or trauma that could cause urinary incontinence or muscle loss. * Presence of psychiatric disorders. * Cognitive impairments. * Use of medications that could affect the study results.
Where it's running
-
Beylikdüzü State Hospital
Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Büşra Şirin Ahısha, MD
- Email: bsrn080@gmail.com
- Phone: (0212) 856 27 40
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How mechanical loading and bone loss change motor neuron reflexes
This study will test whether weight-bearing activities and whole-body vibration change spinal reflex (H-reflex) responses in postmenopausal women with and without osteoporosis.
-
Comparing two treatment regimens for osteoporosis in postmenopausal women
This study is testing two different treatment plans for osteoporosis in postmenopausal women to see which one helps improve bone strength and reduce the risk of fractures better.
-
Combining two medications for treating postmenopausal osteoporosis
This study is testing whether combining two approved medications can help women over 45 with postmenopausal osteoporosis improve their bone health and lower their risk of fractures.
-
Virtual registry for menopause and perimenopause in Australia
This study is creating an online registry to collect information from Australian women about their experiences with menopause and perimenopause to help improve healthcare and support for them.
-
Evaluating treatments after osteoanabolic therapy for osteoporosis
This study is testing different follow-up treatments for Caucasian women with severe osteoporosis after they’ve finished a specific therapy to see which one helps improve their bone health the most.
-
Investigating the effects of romosozumab on bone cells in postmenopausal women
This study is testing how a medication called romosozumab affects bone cells in postmenopausal women who are being treated for osteoporosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.